Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/27/2008US20080293789 Valsartan formulations
11/27/2008US20080293788 Methods and Compositions for the Treatment of Pulmonary Diseases
11/27/2008US20080293787 Pharmaceutical compositions for poorly soluble drugs
11/27/2008US20080293786 Novel 2-imino-1,3-thiazoline-based compounds and t-type calcium channel inhibitors containing the same
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293784 Epothilones c, d, e and f, preparation and compositions
11/27/2008US20080293783 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/27/2008US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
11/27/2008US20080293781 Salicylic Acid Derivatives
11/27/2008US20080293780 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
11/27/2008US20080293779 Methods of treating humans undergoing injection of a contrast agent
11/27/2008US20080293778 Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
11/27/2008US20080293777 Weight Loss Treatment
11/27/2008US20080293776 1,2,5-Thiazolidine Derivatives Useful for Treating Conditions Mediated by Protein Tyrosine Phosphatases (Ptpase)
11/27/2008US20080293775 Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
11/27/2008US20080293774 Treatment of the Symptoms of Bladder Irritation
11/27/2008US20080293773 Amorphous Esomeprazole Hydrate
11/27/2008US20080293772 Salts of picotamide
11/27/2008US20080293771 Azacyclylbenzamide derivatives as histamine-3 antagonists
11/27/2008US20080293770 Psychological disorders; cognition activators
11/27/2008US20080293769 Polymorphs of a C-Met/Hgfr Inhibitor
11/27/2008US20080293768 Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293766 Small-molecule inhibitors of the androgen receptor
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293764 Lpa receptor antagonist
11/27/2008US20080293763 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/27/2008US20080293762 Preventive and Therapeutic medicament for gastroesophageal reflux disease
11/27/2008US20080293761 Pyrrolopyridine-2-Carboxylic Acid Amide Derivative Useful as Inhibitor of Glycogen Phosphorylase
11/27/2008US20080293760 Gemifloxacin Process and Polymorphs
11/27/2008US20080293759 Method for Treating Cancer Based on the Modulation of Calcineurin
11/27/2008US20080293758 Combination of a Steroid Sulfatase Inhibitor and an Ascomycin
11/27/2008US20080293757 Abca1 elevating compounds
11/27/2008US20080293756 4,4-disubstituted piperidine derivatives
11/27/2008US20080293755 Steroidal alkaloids that can be used in the treatment of hedgehog pathway related disorders, particularly cancer and psoriasis
11/27/2008US20080293754 Cyclopamine analogs
11/27/2008US20080293753 Novel Compounds
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293750 Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
11/27/2008US20080293749 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293747 Chemical Synthesis of a Highly Potent Epothilone
11/27/2008US20080293746 Combinations comprising pregabalin
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293744 Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
11/27/2008US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease
11/27/2008US20080293742 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4
11/27/2008US20080293741 Tricyclo Substituted Amides as Glucokinase Modulators
11/27/2008US20080293740 Method of treating acid-sensing ion channel mediated pain, cough suppression, and central nervous system disorders
11/27/2008US20080293739 Compounds for modulating t-cells
11/27/2008US20080293738 Formulation of Quinolinones
11/27/2008US20080293737 Ion channel modulators and methods of use
11/27/2008US20080293736 Compositions, Synthesis, and Methods of Using Quinolinone Based Atypical Antipsychotic Agents
11/27/2008US20080293735 Administering a dopamine/norepinephrine neuronal activity ratio-increasing therapeutic such as GBR 12909 Vanoxerine, (1-(2-[bis(4-Fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride), a specific dopamine reuptake inhibitor
11/27/2008US20080293734 Pharmaceutical compositions
11/27/2008US20080293733 Axl kinase inhibitors
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293731 Organic Compounds
11/27/2008US20080293730 Tricyclo Substituted Amides
11/27/2008US20080293729 Composition and method of decreasing renal ischemic damage
11/27/2008US20080293728 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293726 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
11/27/2008US20080293725 Prognostic Molecular Markers
11/27/2008US20080293724 Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
11/27/2008US20080293723 Spiroindolinone derivatives
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080293720 Pyridinyl Sulfonamide Modulators of Chemokine Receptors
11/27/2008US20080293719 Pyridiazinone Derivatives for the Treatment of Tumours
11/27/2008US20080293718 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
11/27/2008US20080293717 Aryl sulfonamides
11/27/2008US20080293716 Benzamide rho-kinase (ROCK-1) inhibitors; N-(2-phenylethyl)-5-(4-pyridinyl)-2-thiophenecarboxamide
11/27/2008US20080293715 Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles
11/27/2008US20080293714 Tec Kinase Inhibitors
11/27/2008US20080293713 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
11/27/2008US20080293712 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
11/27/2008US20080293711 Chemokine receptor modulators
11/27/2008US20080293710 Aerosol formulation for the inhalation of beta-agonists
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293706 Quinoxaline derivatives as pi3 kinase inhibitors
11/27/2008US20080293705 A1 adenosine receptor antagonists
11/27/2008US20080293704 FACTOR Xa INHIBITORS
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293702 Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
11/27/2008US20080293701 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293699 Inhibitors of thapsigargin-induced cell death
11/27/2008US20080293698 Methods and Compositions for Treating Arg
11/27/2008US20080293697 Pyrazolo[4,3-D]Pyrimidines
11/27/2008US20080293696 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
11/27/2008US20080293695 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
11/27/2008US20080293694 New compounds
11/27/2008US20080293693 Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/27/2008US20080293691 Treatment Method
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293689 Compounds with Atypical Antipsychotic Activity
11/27/2008US20080293688 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
1 ... 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 ... 7860